Since 30.10.2017, the obligatory provision for applicants in drug registration and re-registration is to provide a Risk management plan (read more details in sеction Pharmacovigilance) and clinical data addenda (DCRA, see more details in section Drug clinical review addendum (DCRA). Nowadays, a 2-year transitional period is provided to applicants for preparation of the documents. Up читать дальше…
Our company provides services on conduct of clinical studies with the use of modern diagnostic methods such as: — computerized tomography; — contrast computerized tomography; — magnetic resonance imaging; — ultrasonic diagnostics. We offer a competitive price for a complex examination of patient groups in various phases of clinical studies. As well, you may have читать дальше…
Since January 2017, the Ukrainian Ministry of Health will carry out inspections of compliance with the license conditions for medical practice in accordance with the decree of the Ukrainian Cabinet of Ministers №285 dated 02.03.2016. Firs medical centers which fall under inspections – those which do not comply with the licensing conditions in relation to: читать дальше…
